ImprimisRx offers a look at three new products in the pipeline

ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.

John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting, including:

  • Moxi-Brom (moxifloxacin hydrochloride 0.5% and bromfenac sodium sesquihydrate 0.075%)
  • Klarity-CL drops (cyclosporine 0.1% / loteprednol etabonate 0.2% ophthalmic suspension)
  • Tim-Brim-Dor-Bim (prednisolone acetate 1%, gatifloxacin 0.5%, bromfenac 0.075%).

See more AAO coverage

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.